GGPS1

Geranylgeranyl pyrophosphate synthase is an enzyme that in humans is encoded by the GGPS1 gene.[5][6][7]

GGPS1
Available structures
PDBOrtholog search: PDBe RCSB
Identifiers
AliasesGGPS1, GGPPS, GGPPS1, geranylgeranyl diphosphate synthase 1
External IDsOMIM: 606982 MGI: 1341724 HomoloGene: 31267 GeneCards: GGPS1
EC number2.5.1.1
Gene location (Human)
Chr.Chromosome 1 (human)[1]
Band1q42.3Start235,327,350 bp[1]
End235,344,532 bp[1]
RNA expression pattern


More reference expression data
Orthologs
SpeciesHumanMouse
Entrez

9453

14593

Ensembl

ENSG00000152904

ENSMUSG00000021302

UniProt

O95749

Q9WTN0

RefSeq (mRNA)

NM_001037277
NM_001037278
NM_004837
NM_001371477
NM_001371478

RefSeq (protein)
Location (UCSC)Chr 1: 235.33 – 235.34 MbChr 13: 14.05 – 14.06 Mb
PubMed search[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

Function

This gene is a member of the prenyltransferase family and encodes a protein with geranylgeranyl diphosphate (GGPP) synthase activity. The enzyme catalyzes the synthesis of GGPP from farnesyl diphosphate and isopentenyl diphosphate. GGPP is an important molecule responsible for the C20-prenylation of proteins and for the regulation of a nuclear hormone receptor. Alternate transcriptional splice variants, encoding different isoforms, have been characterized.[7]

Much like its homolog farnesyl diphosphate synthase, GGPS1 is inhibited by bisphosphonate compounds.[8]

Clinical

Mutations in both copies of this gene have been associated with a syndrome of muscular dystrophy, hearing loss and ovarian insufficiency.[9]

References

  1. GRCh38: Ensembl release 89: ENSG00000152904 - Ensembl, May 2017
  2. GRCm38: Ensembl release 89: ENSMUSG00000021302 - Ensembl, May 2017
  3. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. Ericsson J, Greene JM, Carter KC, Shell BK, Duan DR, Florence C, Edwards PA (September 1998). "Human geranylgeranyl diphosphate synthase: isolation of the cDNA, chromosomal mapping and tissue expression". Journal of Lipid Research. 39 (9): 1731–9. doi:10.1016/S0022-2275(20)32159-3. PMID 9741684.
  6. Kainou T, Kawamura K, Tanaka K, Matsuda H, Kawamukai M (March 1999). "Identification of the GGPS1 genes encoding geranylgeranyl diphosphate synthases from mouse and human". Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1437 (3): 333–40. doi:10.1016/S1388-1981(99)00028-1. PMID 10101267.
  7. "Entrez Gene: GGPS1 geranylgeranyl diphosphate synthase 1".
  8. Wiemer AJ, Wiemer DF, Hohl RJ (December 2011). "Geranylgeranyl diphosphate synthase: an emerging therapeutic target". Clinical Pharmacology and Therapeutics. 90 (6): 804–12. doi:10.1038/clpt.2011.215. PMID 22048229. S2CID 27913789.
  9. Foley AR, Zou Y, Dunford JE, Rooney J, Chandra G, Xiong H, Straub V, Voit T, Romero N, Donkervoort S, Hu Y, Markello T, Horn A, Qebibo L, Dastgir J, Meilleur K, Finkel RS, Fan Y, Mamchaoui K, Duguez S, Nelson I, Laporte J, Santi M, Malfatti E, Maisonobe T, Touraine P, Hirano M, Hughes I, Bushby K, Oppermann U, Böhm J, Jaiswal JK, Stojkovic T, Bönnemann CG (2020) GGPS1 mutations cause muscular dystrophy/hearing loss/ovarian insufficiency syndrome. Ann Neurol

Further reading


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.